Anthrax Toxin

Annual Review of Cell and Developmental Biology

Volumn 19, Issue , 2003, Pages 45-70

  Collier, R John ^a   Young, John A T ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Endocytosis; Oligomer; Pore; Receptor; Translocation

Indexed keywords

ANTHRAX TOXIN; ANTIGEN;

ANTIBODY PRODUCTION; CELL COMPARTMENTALIZATION; CHANNEL GATING; CONFERENCE PAPER; CRYSTAL STRUCTURE; CYTOSOL; EDEMA; LETHALITY; LIGAND BINDING; MAMMAL CELL; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN STRUCTURE; PROTEIN TRANSPORT; RECEPTOR BINDING;

ADENYLATE CYCLASE; ANIMALS; ANTHRAX; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; CARRIER PROTEINS; ENDOCYTOSIS; HUMANS; MACROMOLECULAR SUBSTANCES; MODELS, MOLECULAR; PROTEIN TRANSPORT; RECEPTORS, CELL SURFACE;

ANTHRAX; MAMMALIA;

EID: 0344825036     PISSN: 10810706     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.cellbio.19.111301.140655     Document Type: Conference Paper

References (123)

1. Abrami L, Liu S, Cosson P, Leppla SH, Van Der Goot FG. 2003. Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process. J. Cell Biol. 160:321-28
2. Allured VS, Case LM, Leppla SH, McKay DB. 1985. Crystallization of the protective antigen protein of Bacillus anthracis. J. Biol. Chem. 260:5012-13
3. Arora N, Klimpel KR, Singh Y, Leppla SH. 1992. Fusions of anthrax toxin lethal factor to the ADP-ribosylation domain of Pseudomonas exotoxin A are potent cytotoxins which are translocated to the cytosol of mammalian cells. J. Biol. Chem. 267:15542-48
4. Arora N, Leppla SH. 1993. Residues 1-254 of anthrax toxin lethal factor are sufficient to cause cellular uptake of fused polypeptides. J. Biol. Chem. 268:3334-41
5. Arora N, Williamson LC, Leppla SH, Halpern JL. 1994. Cytotoxic effects of a chimeric protein consisting of tetanus toxin light chain and anthrax toxin lethal factor in non-neuronal cells. J. Biol. Chem. 269:26165-71
6. Ascenzi P, Visca P, Ippolito G, Spallarossa A, Bolognesi M, Montecucco C. 2002. Anthrax toxin: a tripartite lethal combination. FEBS Lett. 531:384-88
7. Ballard JD, Collier RJ, Starnbach MN. 1996. Anthrax toxin-mediated delivery of a cytotoxic T-cell epitope in vivo. Proc. Natl. Acad. Sci. USA 93:12531-34
8. Ballard JD, Collier RJ, Starnbach MN. 1998a. Anthrax toxin as a molecular tool for stimulation of cytotoxic T lymphocytes: disulfide-linked epitopes, multiple injections, and role of CD4(+) cells. Infect. Immun. 66:4696-99
9. Ballard JD, Doling AM, Beauregard K, Collier RJ, Starnbach MN. 1998b. Anthrax toxin-mediated delivery in vivo and in vitro of a cytotoxic T-lymphocyte epitope from ovalbumin. Infect. Immun. 66:615-19
10. Beauregard KE, Collier RJ, Swanson JA. 2000. Proteolytic activation of receptor-bound anthrax protective antigen on macrophages promotes its internalization. Cell. Microbiol. 2:251-58
11. Beauregard KE, Wimer-Mackin S, Collier RJ, Lencer WI. 1999. Anthrax toxin entry into polarized epithelial cells. Infect. Immun. 67: 3026-30
12. Bell SE, Mavila A, Salazar R, Bayless KJ, Kanagala S, et al. 2001. Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling. J. Cell Sci. 114:2755-73
13. Benson EL, Huynh PD, Finkelstein A, Collier RJ. 1998. Identification of residues lining the anthrax protective antigen channel. Biochemistry 37:3941-48
14. Bhatnagar R, Friedlander AM. 1994. Protein synthesis is required for expression of anthrax lethal toxin cytotoxicity. Infect. Immun. 62:2958-62
15. Blanke SR, Milne JC, Benson EL, Collier RJ. 1996. Fused polycationic peptide mediates delivery of diphtheria toxin A chain to the cytosol in the presence of anthrax protective antigen. Proc. Natl. Acad. Sci. USA 93:8437-42
16. Blaustein RO, Finkelstein A. 1990. Voltage-dependent block of anthrax toxin channels in planar phospholipid bilayer membranes by symmetric tetraalkylammonium ions. Effects on macroscopic conductance. J. Gen. Physiol. 96:905-19
17. Blaustein RO, Koehler TM, Collier RJ, Finkelstein A. 1989. Anthrax toxin: channel-forming activity of protective antigen in planar phospholipid bilayers. Proc. Natl. Acad. Sci. USA 86:2209-13
18. Blaustein RO, Lea EJ, Finkelstein A. 1990. Voltage-dependent block of anthrax toxin channels in planar phospholipid bilayer membranes by symmetric tetraalkylammonium ions. Single-channel analysis. J. Gen. Physiol. 96:921-42
19. Bradley KA, Mogridge J, Mourez M, Collier RJ, Young JA. 2001. Identification of the cellular receptor for anthrax toxin. Nature 414:225-29
20. Brossier F, Sirard JC, Guidi-Rontani C, Duflot E, Mock M. 1999. Functional analysis of the carboxy-terminal domain of Bacillus anthracis protective antigen. Infect. Immun. 67:964-67
21. Carson-Walter EB, Watkins DN, Nanda A, Vogelstein B, Kinzler KW, St Croix B. 2001. Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res. 61:6649-55
22. Chang SY, Song KP. 2001. ADP-ribosylating binary toxin genes of Clostridium difficile strain CCUG 20309. DNA Seq. 12:115-20
23. Considine RV, Simpson LL. 1991. Cellular and molecular actions of binary toxins possessing ADP-ribosyltransferase activity. Toxicon 29:913-36
24. Cunningham K, Lacy DB, Mogridge J, Collier RJ. 2002. Mapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigen. Proc. Natl. Acad. Sci. USA 99:7049-53
25. Cummings RT, Salowe SP, Cunningham BR, Wiltsie J, Park YW, et al. 2002. A peptide-based fluorescence resonance energy transfer assay for Bacillus anthracis lethal factor protease. Proc. Natl. Acad. Sci. USA 99:6603-6
26. Doling AM, Ballard JD, Shen H, Krishna KM, Ahmed R, et al. 1999. Cytotoxic T-lymphocyte epitopes fused to anthrax toxin induce protective antiviral immunity. Infect. Immun. 67:3290-96
27. Drum CL, Yan SZ, Bard J, Shen YQ, Lu D, et al. 2002. Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin. Nature 415:396-402
28. Duesbery NS, Webb CP, Koochekpour S, Koo HM, et al. 2001. Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways. Proc. Natl. Acad. Sci. USA 98:4089-94
29. Duesbery NS, Webb CP, Leppla SH, Gordon VM, Klimpel KR, et al. 1998. Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 280:734-37
30. Elliott JL, Mogridge J, Collier RJ. 2000. A quantitative study of the interactions of Bacillus anthracis edema factor and lethal factor with activated protective antigen. Biochemistry 39:6706-13
31. Erwin JL, DaSilva LM, Bavari S, Little SF, Friedlander AM, Chanh TC. 2001. Macrophage-derived cell lines do not express proinflammatory cytokines after exposure to Bacillus anthracis lethal toxin. Infect. Immun. 69:1175-77
32. Ezzell JW Jr, Abshire TG. 1992. Serum protease cleavage of Bacillus anthracis protective antigen. J. Gen. Microbiol. 138 (Pt 3): 543-49
33. 2-terminal region and the catalytic domain across planar phospholipid bilayers. Int. J. Med. Microbiol. 290:435-40
34. Friedlander AM. 1986. Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. J. Biol. Chem. 261:7123-26
35. Friedlander AM, Welkos SL, Ivins BE. 2002. Anthrax vaccines. Curr. Top. Microbiol. Immunol. 271:33-60
36. Gao-Sheridan S, Zhang SF, Collier RJ. 2003. Exchange characteristics of calcium ions bound to anthrax protective antigen. Biochem. Biophys. Res. Commun. 300:61-64
37. Goletz TJ, Kumpel KR, Leppla SH, Keith JM, Berzofsky JA. 1997. Delivery of antigens to the MHC class I pathway using bacterial toxins. Hum. Immunol. 54:129-36
38. Gordon VM, Klimpel KR, Arora N, Henderson MA, Leppla SH. 1995. Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases. Infect. Immun. 63:82-87
39. Gordon VM, Leppla SH, Hewlett EL. 1988. Inhibitors of receptor-mediated endocytosis block the entry of Bacillus anthracis adenylate cyclase toxin but not that of Bordetellapertussis adenylate cyclase toxin. Infect. Immun. 56:1066-69
40. Green BD, Battisti L, Koehler TM, Thorne CB, Ivins BE. 1985. Demonstration of a capsule plasmid in Bacillus anthracis. Infect. Immun. 49:291-97
41. Guidi-Rontani C, Mock M. 2002. Macrophage interactions. Curr. Top. Microbiol. Immunol. 271:115-41
42. Guidi-Rontani C, Weber-Levy M, Mock M, Cabiaux V. 2000. Translocation of Bacillus anthracis lethal and oedema factors across endosome membranes. Cell. Microbiol. 2:259-64
43. Hanna PC, Acosta D, Collier RJ. 1993. On the role of macrophages in anthrax. Proc. Natl. Acad. Sci. USA 90:10198-201
44. Hanna PC, Kochi S, Collier RJ. 1992. Biochemical and physiological changes induced by anthrax lethal toxin in J774 macrophage-like cells. Mol. Biol. Cell 3:1269-77
45. Hanna PC, Kruskal BA, Ezekowitz RAB, Bloom BR, Collier RJ. 1994. Role of macrophage oxidative burst in the action of anthrax lethal toxin. Mol. Med. 1:7-18
46. Hoch DH, Romero Mira M, Ehrlich BE, Finkelstein A, DasGupta BR, Simpson LL. 1985. Channels formed by botulinum, tetanus, and diphtheria toxins in planar lipid bilayers: relevance to translocation of proteins across membranes. Proc. Natl. Acad. Sci. USA 82: 1692-96
47. Kagan BL, Finkelstein A, Colombini M. 1981. Diphtheria toxin fragment forms large pores in phospholipid bilayer membranes. Proc. Natl. Acad. Sci. USA 78:4950-54
48. Keim P, Smith KL. 2002. Bacillus anthracis evolution and epidemiology. Curr. Top. Microbiol. Immunol. 271:21-32
49. Klimpel KR, Arora N, Leppla SH. 1993. Anthrax toxin lethal factor has homology to the thermolysin-like proteases and displays protease activity. Abstr. Am. Soc. Microbiol. Annu. Meet. p. 45
50. Klimpel KR, Molloy SS, Thomas G, Leppla SH. 1992. Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin. Proc. Natl. Acad. Sci. USA 89:10277-81
51. Kochi SK, Martin I, Schiavo G, Mock M, Cabiaux V. 1994. The effects of pH on the interaction of anthrax toxin lethal and edema factors with phospholipid vesicles. Biochemistry 33:2604-9
52. Koehler TM, ed. 2002. Anthrax. New York: Springer. Vol. 271
53. Koehler TM, Collier RJ. 1991. Anthrax toxin protective antigen: low-pH-induced hydrophobicity and channel formation in liposomes. Mol. Microbiol. 5:1501-6
54. Koo HM, VanBrocklin M, McWilliams MJ, Leppla SH, Duesbery NS, Woude GF. 2002. Apoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinase. Proc. Natl. Acad. Sci. USA 99:3052-57
55. Lacy DB, Collier RJ. 2002. Structure and function of anthrax toxin. Curr. Top. Microbiol. Immunol. 271:61-85
56. Lacy DB, Mourez M, Fouassier A, Collier RJ. 2002. Mapping the anthrax protective antigen binding site on the lethal and edema factors. J. Biol. Chem. 277:3006-10
57. Lacy DB, Tepp W, Cohen AC, DasGupta BR, Stevens RC. 1998. Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat. Struct. Biol. 5:898-902
58. Leppla SH. 1982. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc. Natl. Acad. Sci. USA 79:3162-66
59. Leppla SH. 1984. Bacillus anthracis calmodulin-dependent adenylate cyclase: chemical and enzymatic properties and interactions with eucaryotic cells. Adv. Cyclic Nucleotide Protein Phosphorylation Res. 17:189-98
60. Leppla SH. 1991. The anthrax toxin complex. In Sourcebook of Bacterial Protein Toxins, ed. J Alouf, pp. 277-302. New York: Academic
61. Leppla SH. 2000. Anthrax toxin. In Bacterial Protein Toxins, ed. K Aktories, I Just, pp. 445-72. Berlin: Springer
62. Little SF, Leppla SH, Burnett JW, Friedlander AM. 1994. Structure-function analysis of Bacillus anthracis edema factor by using monoclonal antibodies. Biochem. Biophys. Res. Commun. 199:676-82
63. Little SF, Leppla SH, Cora E. 1988. Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin. Infect. Immun. 56:1807-13
64. Little SF, Leppla SH, Friedlander AM. 1990. Production and characterization of monoclonal antibodies against the lethal factor component of Bacillus anthracis lethal toxin. Infect. Immun. 58:1606-13
65. Little SF, Novak JM, Lowe JR, Leppla SH, Singh Y, et al. 1996. Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal antibodies. Microbiology 142:707-15
66. Liu S, Leppla SH. 2002. Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization. J. Biol. Chem. 278:5227-34
67. Lu Y, Friedman R, Kushner N, Doling A, Thomas L, et al. 2000. Genetically modified anthrax lethal toxin safely delivers whole HIV protein antigens into the cytosol to induce T cell immunity. Proc. Natl. Acad. Sci. USA 97:8027-32
68. Maynard JA, Maassen CB, Leppla SH, Brasky K, Patterson JL, et al. 2002. Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity. Nat. Biotechnol. 20:597-601
69. Menard A, Altendorf K, Breves D, Mock M, Montecucco C. 1996. The vacuolar ATPase proton pump is required for the cytotoxicity of Bacillus anthracis lethal toxin. FEBS Lett. 386:161-64
70. Miller CJ, Elliott JL, Collier RJ. 1999. Anthrax protective antigen: prepore-to-pore conversion. Biochemistry 38:10432-41
71. Milne JC, Collier RJ. 1993. pH-dependent permeabilization of the plasma membrane of mammalian cells by anthrax protective antigen. Mol. Microbiol. 10:647-53
72. Milne JC, Furlong D, Hanna PC, Wall JS, Collier RJ. 1994. Anthrax protective antigen forms oligomers during intoxication of mammalian cells. J. Biol. Chem. 269:20607-12
73. Mock M, Fouet A. 2001. Anthrax. Annu. Rev. Microbiol. 55:647-71
74. Mogridge J, Cunningham K, Collier RJ. 2002a. Stoichiometry of anthrax toxin complexes. Biochemistry 41:1079-82
75. Mogridge J, Cunningham K, Lacy DB, Mourez M, Collier RJ. 2002b. The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen. Proc. Natl. Acad. Sci. USA 99:7045-48
76. Mogridge J, Mourez M, Collier RJ. 2001. Involvement of domain 3 in oligomerization by the protective antigen moiety of anthrax toxin. J. Bacteriol. 183:2111-16
77. Molloy SS, Bresnahan PA, Leppla SH, Klimpel KR, Thomas G. 1992. Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen. J. Biol. Chem. 267:16396-402
78. Moriya O, Matsui M, Osorio M, Miyazawa H, Rice CM, et al. 2001. Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells treated with an anthrax toxin fusion protein. Vaccine 20:789-96
79. Mourez M, Kane RS, Mogridge J, Metallo S, Deschatelets P, et al. 2001. Designing a polyvalent inhibitor of anthrax toxin. Nat. Biotechnol. 19:958-61
80. Mourez M, Lacy DB, Cunningham K, Legmann R, Sellman BR, et al. 2002. 2001: a year of major advances in anthrax toxin research. Trends Microbiol. 10:287-93
81. Nassi S, Collier RJ, Finkelstein A. 2002. PA63 channel of anthrax toxin: an extended beta-barrel. Biochemistry 41:1445-50
82. Novak JM, Stein MP, Little SF, Leppla SH, Friedlander AM. 1992. Functional characterization of protease-treated Bacillus anthracis protective antigen. J. Biol. Chem. 267:17186-93
83. Novoa I, Cotten M, Carrasco L. 1996. Hybrid proteins between Pseudomonas aeruginosa exotoxin A and poliovirus 2Apro cleave p220 in HeLa cells. J. Virol. 70:3319-24
84. O'Brien J, Friedlander A, Dreier T, Ezzell J, Leppla S. 1985. Effects of anthrax toxin components on human neutrophils. Infect. Immun. 47:306-10
85. O'Keefe DO, Cabiaux V, Choe S, Eisenberg D, Collier RJ. 1992. pH-dependent insertion of proteins into membranes: B-chain mutation of diphtheria toxin that inhibits membrane translocation, Glu-349-Lys. Proc. Natl. Acad. Sci. USA 89:6202-6
86. Okinaka RT, Cloud K, Hampton O, Hoffmaster AR, Hill KK, et al. 1999. Sequence and organization of pXO1, the large Bacillus anthracis plasmid harboring the anthrax toxin genes. J. Bacteriol. 181:6509-15
87. Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, et al. 2001. Crystal structure of the anthrax lethal factor. Nature 414:229-33
88. Park JM, Greten FR, Li ZW, Karin M. 2002. Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science 297:2048-51
89. Pellizzari R, Guidi-Rontani C, Vitale G, Mock M, Montecucco C. 1999. Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNgamma-induced release of NO and TNFalpha. FEBS Lett. 462:199-204
90. Petosa C, Collier RJ, Klimpel KR, Leppla SH, Liddington RC. 1997. Crystal structure of the anthrax toxin protective antigen. Nature 385:833-38
91. Popoff MR, Boquet P. 1988. Clostridium spiroforme toxin is a binary toxin which ADP-ribosylates cellular actin. Biochem. Biophys. Res. Commun. 152:1361-68
92. Ratts R, Zeng H, Berg EA, Blue C, McComb ME, et al. 2003. The cytosolic entry of diphtheria toxin catalytic domain requires a host cell cytosolic translocation factor complex. J. Cell. Biol. 160:1139-50
93. Roberts JE, Watters JW, Ballard JD, Dietrich WF. 1998. Ltx1, a mouse locus that influences the susceptibility of macrophages to cytolysis caused by intoxication with Bacillus anthracis lethal factor, maps to chromosome 11. Mol. Microbiol. 29:581-91
94. Sandvig K, Van Deurs B. 2002. Membrane traffic exploited by protein toxins. Annu. Rev. Cell Dev. Biol. 18:1-24
95. Scobie HM, Rainey GTA, Bradley KA, Young JAT. 2003. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc. Natl. Acad. Sci. USA 100: 5170-74
96. Sellman BR, Mourez M, Collier RJ. 2001a. Dominant-negative mutants of a toxin subunit: an approach to therapy of anthrax. Science 292:695-97
97. Sellman BR, Nassi S, Collier RJ. 2001b. Point mutations in anthrax protective antigen that block translocation. J. Biol. Chem. 276:8371-76
98. Shen Y, Lee YS, Soelaiman S, Bergson P, Lu D, et al. 2002. Physiological calcium concentrations regulate calmodulin binding and catalysis of adenylyl cyclase exotoxins. EMBO J. 21:6721-32
99. Shimaoka M, Takagi J, Springer TA. 2002. Conformational regulation of integrin structure and function. Annu. Rev. Biophys. Biomol. Struct. 31:485-516
100. Silverman JA, Mindell JA, Finkelstein A, Shen WH, Collier RJ. 1994. Mutational analysis of the helical hairpin region of diphtheria toxin transmembrane domain. J. Biol. Chem. 269:22542-32
101. Simpson LI. 1989. The binary toxin produced by Clostridium botulinum enters cells by receptor-mediated endocytosis to exert its pharmacologic effects. J. Pharmacol. Exp. Ther. 251:1223-28
102. Singh Y, Khanna H, Chopra AP, Mehra V. 2001. A dominant negative mutant of Bacillus anthracis protective antigen inhibits anthrax toxin action in vivo. J. Biol. Chem. 276:22090-94
103. Singh Y, Klimpel KR, Arora N, Sharma M, Leppla SH. 1994. The chymotrypsin-sensitive site, FFD315, in anthrax toxin protective antigen is required for translocation of lethal factor. J. Biol. Chem. 269:29039-46
104. Singh Y, Klimpel KR, Goel S, Swain PK, Leppla SH. 1999. Oligomerization of anthrax toxin protective antigen and binding of lethal factor during endocytic uptake into mammalian cells. Infect. Immun. 67:1853-59
105. Singh Y, Klimpel KR, Quinn CP, Chaudhary VK, Leppla SH. 1991. The carboxyl-terminal end of protective antigen is required for receptor binding and anthrax toxin activity. J. Biol Chem. 266:15493-97
106. Smith H. 2000. Discovery of the anthrax toxin: the beginning of in vivo studies on pathogenic bacteria. Trends Microbiol. 8: 199-200
107. Smith H, Stoner HB. 1967. Anthrax toxic complex. Fed. Proc. 26:1554-57
108. Song L, Hobaugh MR, Shustak C, Cheley S, Bayley H, Gouaux JE. 1996. Structure of staphylococcal alpha-hemolysin, a heptameric transmembrane pore. Science 274: 1859-66
109. St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, et al. 2000. Genes expressed in human tumor endothelium. Science 289:1197-202
110. Tang G, Leppla SH. 1999. Proteasome activity is required for anthrax lethal toxin to kill macrophages. Infect. Immun. 67:3055-60
111. Tonello F, Seveso M, Marin O, Mock M, Montecucco C. 2002. Screening inhibitors of anthrax lethal factor. Nature 418:386
112. Turnbull PC. 2002. Introduction: anthrax history, disease and ecology. Curr. Top. Microbiol. Immunol. 271:1-19
113. Varshavsky A. 1997. The N-end rule pathway of protein degradation. Genes Cells 2:13-28
114. Varughese M, Teixeira AV, Liu S, Leppla SH. 1999. Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin. Infect. Immun. 67:1860-65
115. Vitale G, Pellizzari R, Recchi C, Napolitani G, Mock M, Montecucco C. 1998. Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. Biochem. Biophys. Res. Commun. 248:706-11
116. Walker B, Bayley H. 1995. Key residues for membrane binding, oligomerization, and pore forming activity of staphylococcal alpha-hemolysin identified by cysteine scanning mutagenesis and targeted chemical modification. J. Biol. Chem. 270:23065-71
117. Wang XM, Mock M, Ruysschaert JM, Cabiaux V. 1996. Secondary structure of anthrax lethal toxin proteins and their interaction with large unilamellar vesicles: a Fourier-transform infrared spectroscopy approach. Biochemistry 35:14939-46
118. Watters JW, Dewar K, Lehoczky J, Boyartchuk V, Dietrich WF. 2001. Kif1C, a kinesin-like motor protein, mediates mouse macrophage resistance to anthrax lethal factor. Curr. Biol. 11:1503-11
119. Watters JW, Dietrich WF. 2001. Genetic, physical, and transcript map of the Ltxs1 region of mouse chromosome 11. Genomics 73:223-31
120. Wesche J, Elliott JL, Falnes PO, Olsnes S, Collier RJ. 1998. Characterization of membrane translocation by anthrax protective antigen. Biochemistry 37:15737-46
121. Whittaker CA, Hynes RO. 2002. Distribution and evolution of von Willebrand/integrin a domains: widely dispersed domains with roles in cell adhesion and elsewhere. Mol. Biol. Cell 13:3369-87
122. Yan M, Collier RJ. 2003. Characterization of dominant-negative forms of anthrax protective antigen. Mol. Med. 9:46-51
123. Zhao J, Milne JC, Collier RJ. 1995. Effect of anthrax toxin's lethal factor on ion channels formed by the protective antigen. J. Biol. Chem. 270:18626-30